Literature DB >> 20424914

Granzyme A and thrombin differentially promote the release of interleukin-8 from alveolar epithelial A549 cells.

Yumiko Yoshikawa1, Hirofumi Hirayasu, Satoshi Tsuzuki, Tohru Fushiki.   

Abstract

Some of extracellular serine proteases with trypsin-like specificity of cleavage have been known to increase the release of inflammatory mediators from various cell types. For instance, two well-known trypsin-like serine proteases circulating in blood, granzyme A (GrA) and thrombin, have been found to promote interleukin (IL)-8 release from an alveolar epithelial A549 cell line. However, the mechanisms by which the proteases promote IL-8 release from the cells are not fully understood. In the present study, using A549 cells we found that (1) thrombin promoted IL-8 release from the cells via a mechanism partially involving activation of protease-activated receptor-1, a G-protein coupled receptor, whereas a recombinant form of GrA (rGrA) did it via a mechanism that does not involve the receptor activation; that (2) unlike rGrA, thrombin did not cause detachment and microtubule disruption of the cells; and that (3) the release of IL-8 induced by rGrA was inhibited in the presence of taxol, a microtubule-stabilizing reagent, whereas that induced by thrombin was not. These findings suggest that rGrA and thrombin promote the release of IL-8 from A549 cells through distinct mechanisms.

Entities:  

Year:  2010        PMID: 20424914      PMCID: PMC2978307          DOI: 10.1007/s10616-010-9275-z

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  20 in total

1.  Inhibition of cellular action of thrombin by N3-cyclopropyl-7-[[4-(1-methylethyl)phenyl]methyl]-7H-pyrrolo[3, 2-f]quinazoline-1,3-diamine (SCH 79797), a nonpeptide thrombin receptor antagonist.

Authors:  H S Ahn; C Foster; G Boykow; A Stamford; M Manna; M Graziano
Journal:  Biochem Pharmacol       Date:  2000-11-15       Impact factor: 5.858

Review 2.  Granzymes (lymphocyte serine proteases): characterization with natural and synthetic substrates and inhibitors.

Authors:  C M Kam; D Hudig; J C Powers
Journal:  Biochim Biophys Acta       Date:  2000-03-07

Review 3.  Death by a thousand cuts: granzyme pathways of programmed cell death.

Authors:  Dipanjan Chowdhury; Judy Lieberman
Journal:  Annu Rev Immunol       Date:  2008       Impact factor: 28.527

Review 4.  Proteinase-activated receptors: transducers of proteinase-mediated signaling in inflammation and immune response.

Authors:  Martin Steinhoff; Jörg Buddenkotte; Victoria Shpacovitch; Anke Rattenholl; Corinna Moormann; Nathalie Vergnolle; Thomas A Luger; Morley D Hollenberg
Journal:  Endocr Rev       Date:  2005-02       Impact factor: 19.871

5.  Extracellular activities of human granzymes. I. Granzyme A induces IL6 and IL8 production in fibroblast and epithelial cell lines.

Authors:  L E Sower; G R Klimpel; W Hanna; C J Froelich
Journal:  Cell Immunol       Date:  1996-07-10       Impact factor: 4.868

6.  Purification and identification of a binding protein for pancreatic secretory trypsin inhibitor: a novel role of the inhibitor as an anti-granzyme A.

Authors:  Satoshi Tsuzuki; Yoshimasa Kokado; Shigeki Satomi; Yoshie Yamasaki; Hirofumi Hirayasu; Toshihiko Iwanaga; Tohru Fushiki
Journal:  Biochem J       Date:  2003-05-15       Impact factor: 3.857

7.  Granzyme activity in the inflamed lung is not controlled by endogenous serine proteinase inhibitors.

Authors:  G M Tremblay; A M Wolbink; Y Cormier; C E Hack
Journal:  J Immunol       Date:  2000-10-01       Impact factor: 5.422

8.  Cleavage of the thrombin receptor: identification of potential activators and inactivators.

Authors:  M A Parry; T Myles; J Tschopp; S R Stone
Journal:  Biochem J       Date:  1996-11-15       Impact factor: 3.857

9.  A lymphocyte serine protease granzyme A causes detachment of a small-intestinal epithelial cell line (IEC-6).

Authors:  Hirofumi Hirayasu; Yumiko Yoshikawa; Satoshi Tsuzuki; Tohru Fushiki
Journal:  Biosci Biotechnol Biochem       Date:  2008-09-07       Impact factor: 2.043

10.  Granzyme A is an interleukin 1 beta-converting enzyme.

Authors:  M Irmler; S Hertig; H R MacDonald; R Sadoul; J D Becherer; A Proudfoot; R Solari; J Tschopp
Journal:  J Exp Med       Date:  1995-05-01       Impact factor: 14.307

View more
  3 in total

1.  Modulation of protease activated receptor 1 influences human metapneumovirus disease severity in a mouse model.

Authors:  Laetitia Aerts; Marie-Ève Hamelin; Chantal Rhéaume; Sophie Lavigne; Christian Couture; Woojin Kim; Delia Susan-Resiga; Annik Prat; Nabil G Seidah; Nathalie Vergnolle; Beatrice Riteau; Guy Boivin
Journal:  PLoS One       Date:  2013-08-28       Impact factor: 3.240

2.  Perforin and granzyme B have separate and distinct roles during atherosclerotic plaque development in apolipoprotein E knockout mice.

Authors:  Paul R Hiebert; Wendy A Boivin; Hongyan Zhao; Bruce M McManus; David J Granville
Journal:  PLoS One       Date:  2013-10-24       Impact factor: 3.240

3.  Granzymes A and K differentially potentiate LPS-induced cytokine response.

Authors:  Annette C Wensink; Helena M Kok; Jan Meeldijk; Job Fermie; Christopher J Froelich; C Erik Hack; Niels Bovenschen
Journal:  Cell Death Discov       Date:  2016-12-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.